Methylation of CDH11is an Independent Prognostic Biomarker for Gastric Cancer Patients
محل انتشار: چهارمین کنگره بین المللی سرطان های دستگاه گوارش
سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 407
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CANCERMED04_053
تاریخ نمایه سازی: 17 مرداد 1398
چکیده مقاله:
Introduction & Aim: Gastric cancer is an aggressive malignancy which is the fourth most common cancer in the world. Epigenetic alterations including DNA methylation of tumor suppressor genes can promote cancer development. Cadherin 11 (CDH11) is a novel tumor suppressor gene which is methylated in several human cancers. The aim of this study is investigation of methylation status of CDH11 in gastric cancer samples for the first time. Methods About 12 formalin-fixed paraffin-embedded (FFPE) gastric adenocarcinoma samples were obtained from department of Pathology of Imam Reza hospital, Tabriz, IRAN. DNA extraction was performed using a modified salting out method. The methylation status was verified by methylation-specific PCR (MSP) technique. DNA was converted by sodium bisulphite treatment using Epizen DNA Methylation Kit and used in PCR with specific primers for cadherin-11 promoter region. Four normal samples were used as control. Results: Results showed that 8 out of 12 tumor DNA samples (66.66%) are methylated. In contrast, all normal tissues were unmethylated. Conclusion: Here, we showed that CG sites covering the cadherin-11 promoter region are frequently methylated in gastric cancer patients. Therefore, CDH11 methylation status may be used as an independent prognostic biomarker for gastric cancer patients.
نویسندگان
Shirin Eyvazi
Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Vahideh Tarhriz
Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Amir Mahdi Khamaneh
Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Bita Sepehri
Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran